Centralised Licensing With Inadequate Staff May Lead To Delay In Granting Product Licences

Pharmaceutical companies in the country may have to cope with serious delays in getting their applications for drug licenses cleared once Central Drugs Authority (CDA) of India is formed. Such delays in the initial phase of its existence are inevitable as the staff strength of Central Drugs Control Organisation is highly inadequate to handle the vast number of applications that may pour in from various states, according to All India Drug Control Officers Association (AIDCOC).

Central Drug Authority Will Be Formed In Six Months : Dr Ramadoss

The much awaited Central Drugs Authority of India (CDA (I), stated to be formed in line with the US FDA would be ready within six months from now. The meeting was held to discuss relevant issues about the same and it was cleared by the cabinet. The issue to set up the CDA (I) had been pending for the last many years and the final decision to set it up had been taken on Thursday.

Fresenius Medical Picks Up Majority Stake In Taiwanese Dialysis Firm

Fresenius Medical Care AG & Co. KGaA continues to expand in Asia. The company announced the acquisition of a 51 per cent equity interest in Jiate Excelsior Co. Ltd. (Excelsior) in Taiwan. With a market share of approximately 14 percent Excelsior is the largest dialysis service provider in Taiwan treating over6,500 hemodialysis patients in 90 clinics.

The Corporate Healthcare Segment May Replicate The Success Of The Indian IT Sector, Say Experts

The corporatisation of the Indian hospital sector has begun in a big way. Well known corporates such as Escorts and Apollo are already in expansion mode.

IPR Comes With New Hi-tech Medical Waste Disposable Plan For Hospitals

Hospitals may soon be able to dispose off medical wastes in an eco-friendly manner using a new technology. Gandhinagar based Institute of Plasma Research (IPR) has developed a new non-burn technology - plasma pyrolysis process - which will make it possible to dispose off medical wastes without using traditional methods of burning or dumping the same.

Fresenius To Expand Dialyzer Production Capacity At St Wandel

Fresenius Medical Care is expanding the dialyzer production capacity at the St. Wandel (Germany) production facility by 40 percent. A total of 36 million will be invested including associated investment in additional production capacity for proprietary Helixone Fibers.

Marck Biosciences In Talks With US Cos For Site Transfer

Marck Biosciences is talking to several US based pharma companies for a site transfer deal, through which it can undertake contract manufacturing of small volume parenterals and injectibles at its facility in Gujarat. Through this process, an US based pharma company move its production of a particular molecule to India by getting US FDA approval for Marck's production facility.

Ranbaxy Group Forays Into Retail Healthcare

The Ranbaxy promoter group will mark its foray into healthcare retail through a new company, Fortis Health World, which plans to set up 1,000 HealthWorld store in 400 cities in the next five years at an outlay of Rs. 800 crore.

Corona Cardiac Cathlab

Hospital visits can be harrowing experiences, but thanks to Design Directions, this cardiac system is not only full of mind boggling science, but it also offers impressive comfort.